381 related articles for article (PubMed ID: 22303913)
1. Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.
Morren JA; Galvez-Jimenez N
Expert Opin Investig Drugs; 2012 Mar; 21(3):297-320. PubMed ID: 22303913
[TBL] [Abstract][Full Text] [Related]
2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
3. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
Cheah BC; Vucic S; Krishnan AV; Kiernan MC
Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
[TBL] [Abstract][Full Text] [Related]
4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
[TBL] [Abstract][Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Moore DH
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
[TBL] [Abstract][Full Text] [Related]
6. Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials.
Barp A; Gerardi F; Lizio A; Sansone VA; Lunetta C
Expert Opin Emerg Drugs; 2020 Jun; 25(2):145-164. PubMed ID: 32456491
[TBL] [Abstract][Full Text] [Related]
7. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.
Jaiswal MK
Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496
[TBL] [Abstract][Full Text] [Related]
8. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
Bellingham MC
CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
[TBL] [Abstract][Full Text] [Related]
9. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
Noto Y; Shibuya K; Vucic S; Kiernan MC
Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
[TBL] [Abstract][Full Text] [Related]
10. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
Goyal NA; Mozaffar T
Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing a patient's decision regarding riluzole: an early experience.
Rudnicki SA
J Neurol Sci; 1997 Oct; 152 Suppl 1():S80-1. PubMed ID: 9419060
[TBL] [Abstract][Full Text] [Related]
12. Riluzole for the treatment of amyotrophic lateral sclerosis.
Saitoh Y; Takahashi Y
Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
[TBL] [Abstract][Full Text] [Related]
13. Management of amyotrophic lateral sclerosis with riluzole.
Neatherlin JS
J Neurosci Nurs; 1998 Aug; 30(4):257-60. PubMed ID: 9791781
[TBL] [Abstract][Full Text] [Related]
14. [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].
Kollewe K; Dengler R; Petri S
Nervenarzt; 2008 Jun; 79(6):653-61. PubMed ID: 18210046
[TBL] [Abstract][Full Text] [Related]
15. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
Roch-Torreilles I; Camu W; Hillaire-Buys D
Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
[TBL] [Abstract][Full Text] [Related]
16. Edaravone for the treatment of amyotrophic lateral sclerosis.
Yoshino H
Expert Rev Neurother; 2019 Mar; 19(3):185-193. PubMed ID: 30810406
[TBL] [Abstract][Full Text] [Related]
17. Reversible granulocytopenia in association with riluzole therapy.
North WA; Khan AM; Yamase HT; Sporn JR
Ann Pharmacother; 2000 Mar; 34(3):322-4. PubMed ID: 10917377
[TBL] [Abstract][Full Text] [Related]
18. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.
Wei Y; Zhong S; Yang H; Wang X; Lv B; Bian Y; Pei Y; Xu C; Zhao Q; Wu Y; Luo D; Wang F; Sun H; Chen Y
Eur J Med Chem; 2024 Jun; 272():116496. PubMed ID: 38759454
[TBL] [Abstract][Full Text] [Related]
19. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
Yanagisawa N; Shindo M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents.
Johnson SA; Fang T; De Marchi F; Neel D; Van Weehaeghe D; Berry JD; Paganoni S
Drugs; 2022 Sep; 82(13):1367-1388. PubMed ID: 36121612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
